Ipratropijev bromid/salbutamol Cipla 0,5 mg/2,5 mg u 2,5 ml, otopina za atomizator
| Name | Ipratropijev bromid/salbutamol Cipla 0,5 mg/2,5 mg u 2,5 ml, otopina za atomizator |
|---|---|
| Marketing Authorisation Number | HR-H-807555647 |
| Active Substance | ipratropijev bromid hidrat salbutamolsulfat |
| Composition | jedna ampula od 2,5 ml sadrži 0,5 mg ipratropijevog bromida (525 mikrograma u obliku ipratropijevog bromida, hidrata) i 2,5 mg salbutamola (u obliku sulfata) |
| Pharmaceutical Form | otopina za atomizator |
| Manufacturer | Cipla Europe NV, Antwerpen, Belgija Orion Corporation, Orion Pharma, Espoo, Finska Orion Corporation, Orion Pharma, Salo, Finska Amring Farma S.R.L., Bukurešt, Rumunjska S&D Pharma CZ, spol. s r.o, Pchery (Pharmos a.s. facility), Češka |
| Marketing Authorisation Holder | Cipla Europe NV, De Keyserlei 58-60, Box-19, Antwerpen, Belgija |
| Marketing Authorisation Date | 02.08.2019 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/18-02/333 |
| Registration Number | 381-12-01/30-19-03 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | R03AL02 |
| Medicinal product marketed in the Croatia | Nestašica |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
